Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefitdoi:10.1007/s00262-021-03075-3Cancer Immunology, Immunotherapy - Epstein-Barr virus (EBV) is associated with nasopharyngeal carcinoma (NPC), and provides a ...